About this episode
WTFinance are happy to welcome Dr Simon Barnes as our second podcast guest.
Dr Barnes career began in academia and research, completing a bachelors and PhD at Cambridge University in Plant Molecular Biology and Bio Chemistry, undertaking a NATO Research Fellowship at Rockefeller University in New York and was Head of the Laboratory of Cotton Biotechnology in Singapore. He then pivoted to start a career in Venture Capital, looking to commercialise the scientific advancements he was seeing first hand. He studied an MBA at Imperial College London and later was Director of Imperial's Entrepreneurship Centre where he co-authored "Raising Venture Capital".
He has since worked at Atlas Ventures, Gimv and has co-founded Circadia Ventures, raising £55 million under management on behalf of Tate & Lyle. This has led to him investing in and being a Director of Evolve Biosystems, Changing Health and Prolypin GmbH.
Simon talks about his career in Venture Capital, advice on people looking to pursue a career in VC and thoughts on the landscape of VC now and into the future.
If you have any questions or want to get in contact with Simon - [email protected]
WTFinance Platforms -
Instagram - https://www.instagram.com/wtfinancee/
Youtube - https://www.youtube.com/channel/UCPI-DJWmId3Y-Dd1yI8LDnw
Get every episode summarized
Each time WTFinance publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from WTFinance
Iran, China & Russia Are the Winners of the War | Vali Nasr
WTFinance
The Bond Market is Hitting its Breaking Point! Steve Hanke
WTFinance
Gold vs. The Dollar: Why the Global Hegemony is Ending | Matthew Piepenburg
WTFinance
The Middle East, US Sanctions, and the Coming Economic Shift | Doomberg
WTFinance